Eric Verdin

President and CEO, Buck Institute for Research on Aging · Elected Member, National Academy of Medicine of Belgium · Authority on Longevity and Healthy Aging

Inquire to book
Eric Verdin portrait
Eric Verdin shows leaders how to turn longevity from a healthcare cost into a strategic opportunity. His research on resilience, metabolism and peak performance reveals how healthier, longer lives will reshape workforce well-being in every industry.
San Francisco, United States
Videos

Watch Eric in Action

Breakthroughs in Aging Research | Dr. Eric Verdin, 2024 Longevity Summit | Aviv Clinics

Ketogenic Diet, Longevity, Beta-Hydroxybutyrate, HDAC Inhibitors, & NAD+ (Video)

Bio

About Eric Verdin

Eric Verdin, M.D., has helped shape major advances in the science of healthy aging, and he now translates that work for CEOs, investors, policy makers and corporate leaders. He has appeared at TEDMED, the Milken Institute, Aspen Ideas, HLTH and Fortune Brainstorm Health, and his research has been featured in The New York Times, The Wall Street Journal, Fortune and Scientific American.

For executive audiences, Verdin's message is both urgent and optimistic: longevity is no longer only a healthcare issue but a leadership, workforce and business issue. He challenges the assumption that longer lives simply mean higher costs and an older workforce. The frontier, he argues, is not extending lifespan but extending healthspan, the years people remain healthy, productive and engaged. Organizations that understand this shift can build strategies around resilience, sustained peak performance and well-being rather than reactive care.

Topics

Eric's Keynote Topics

Most of what we call aging is not inevitable decline but the accumulation of biological processes we can now measure and, in many cases, slow or reverse. Eric Verdin, M.D., president and CEO of the Buck Institute for Research on Aging, explains how advances in metabolic science, inflammation research and cellular biology are rewriting the rules of healthy aging.

Verdin walks audiences through the key drivers of aging: chronic inflammation, metabolic dysfunction, mitochondrial decline and immune system aging. He shows how interventions once dismissed as fringe (fasting, ketone signaling, NAD+ supplementation) are now supported by rigorous research, and explains what the data actually show versus what the longevity industry claims.

Drawing on his pioneering work demonstrating that ketone bodies are signaling molecules that influence inflammation and gene expression, and his research on metabolism, epigenetics and immune aging, Verdin gives leaders in health care, biotechnology and life sciences a clear view of where the science stands, what interventions have evidence behind them, and how biological age is replacing chronological age as the metric that matters.

Audiences leave understanding the difference between hype and science, what biomarkers reveal about aging and disease risk, and how prevention is shifting from theory to measurable practice.

Collections

From Eric's desk

Podcast

We're not getting any younger...yet podcast with Eric Verdin and Brianna Stubbs

Listen
Inquiries

Bring Eric to your next event

Tell us about your event and we will be in touch right away.

Step 1 submitted, your details are with us.

A few more optional questions help us come back with something specific. Skip any of them.

Format

Thank you, your inquiry is on its way.

A Stellant advisor will be in touch shortly about Eric Verdin.

Contact Eric Verdin